Igyxos Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $8.49M
Latest Deal Amount
  • Investors
  • 7

Igyxos General Information

Description

Developer of pharmaceuticals and medical technologies intended to improve fertility and human reproductive health. The company's technologies focus on the field of human fertility by shifting hormonal imbalances with a new method using monoclonal antibodies, enabling patients to have alternative ways to cure infertility and enhance reproductive health.

Contact Information

Website
www.igyxos.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Biotechnology
Primary Office
  • Centre INRA Val de Loire
  • Site de Tours
  • 37380 Nouzilly
  • France
+33 02 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Igyxos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 21-Mar-2019 $8.49M 00.000 Completed Startup
To view Igyxos’s complete valuation and funding history, request access »

Igyxos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of pharmaceuticals and medical technologies intended to improve fertility and human reproductive health. The c
Pharmaceuticals
Nouzilly, France
6 As of 2021
00.000
00000000000 00.000

000000

t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliq
0000000000000
Geneva, Switzerland
00 As of 0000
00000
00000000

0000000

s aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
0000 000000000
Turku, Finland
00 As of 0000
000.00
00.00 0000-00-00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Igyxos Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ObsEva Formerly VC-backed Geneva, Switzerland 00 00000 00000000
0000000 000000 Venture Capital-Backed Turku, Finland 00 000.00 0000000000 0 000.00
00000000 Venture Capital-Backed New York, NY 00 000.00 00000000000 000.00
000000 00000000000 Corporation Herndon, VA
To view Igyxos’s complete competitors history, request access »

Igyxos Patents

Igyxos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2797752-T3 Ligands that enhance the bioactivity of gonadotropins Active 10-Sep-2014 000000000
FR-3025518-A1 Ligands potentiating the bioactivity of gonadotrophins Granted 10-Sep-2014 000000000 0
FR-3025517-A1 Ligands potentiating the bioactivity of gonadotrophins Granted 10-Sep-2014 000000000 0
FR-3025518-B1 Ligands potentiating the bioactivity of gonadotrophins Active 10-Sep-2014 000000000
JP-6705608-B2 Ligands that enhance the bioactivity of gonadotropins Active 10-Sep-2014 C07K16/26

Igyxos Executive Team (2)

Name Title Board Seat Contact Info
Pierre-Henry Longeray Chief Executive Officer, Managing Director & General Manager
Marie-Christine Maurel Founder, President, CSO, Board Member & Deputy General Manager
To view Igyxos’s complete executive team members history, request access »

Igyxos Board Members (4)

Name Representing Role Since
Benoit Barteau Ph.D Bpifrance Board Member 000 0000
François Miceli Sofimac Innovation Board Member 000 0000
Herve Bachelot Lallier GO Capital (France) Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Igyxos Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Igyxos Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Apicap Venture Capital Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Centre Capital Développement Venture Capital Minority 000 0000 000000 0
Emergence (Incubation) Asset Manager Minority 000 0000 000000 0
GO Capital (France) Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »